Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2011-6-22
pubmed:abstractText
The fragile X-associated tremor/ataxia syndrome (FXTAS) is a late-onset neurodegenerative disorder caused by expansions of 55-200 CGG repeats in the 5'UTR of the FMR1 gene. These FMR1 premutation expansions have relatively high frequency in the general population. To estimate the frequency of FMR1 premutations among Portuguese males with non-familial, late-onset movement disorders of unknown etiology, we assessed CGG repeat size in males with disease onset after the age of 50 and negative or unknown family history for late-onset movement disorders, who were sent for SCA, HD, or PD genetic testing at a reference laboratory. The selected patients had a primary clinical diagnosis based on one of the following cardinal features of FXTAS: ataxia, tremor, or cognitive decline. A total of 86 subjects were genotyped for the CGG repeat in the FMR1 gene. We detected one patient with an expansion in the premutation range. The frequency of FMR1 premutations was 1.9% (1/54) in our group of patients with ataxia as the primary clinical feature, and 1.2% (1/86) in the larger movement disorders group. In the family of the FXTAS case, premutation-transmitting females presented a history of psychiatric symptoms, suggesting that, given the wide phenotypical expression of the premutation in females, neuropsychiatric surveillance is necessary. In conclusion, genetic testing for FXTAS should be made available to patients with adult-onset movement disorders to enable adequate genetic counseling to family members.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-10331589, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-11388762, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-11445641, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-12135967, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-12612802, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-12638084, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-12905066, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-14747503, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-14994246, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15052536, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15065016, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15277639, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15300658, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15390127, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15483640, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15546601, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15592742, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15592745, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15608041, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15642922, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15889413, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15947063, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-15956167, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-1710175, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-17179750, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-17618523, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-17917121, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-18273822, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-18363164, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-18373410, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-18686748, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-1878973, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-19235102, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-19259763, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-20497189, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-20816038, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-20938029, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-8825491, http://linkedlifedata.com/resource/pubmed/commentcorrection/21639881-9973286
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1744-9081
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
7
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
19
pubmed:meshHeading
pubmed:year
2011
pubmed:articleTitle
FXTAS is rare among Portuguese patients with movement disorders: FMR1 premutations may be associated with a wider spectrum of phenotypes.
pubmed:affiliation
UnIGENe, IBMC - Instituto de Biologia Molecular e Celular, Universidade do Porto, Porto, Portugal.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't